- Home
- ORRF vs BBOT Comparison
ORRF vs BBOT Comparison
Compare ORRF & BBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ORRF | BBOT |
|---|---|---|
| Founded | 1919 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 791.0M | 717.8M |
| IPO Year | 1995 | 2024 |
Fundamental Metrics
Financial Performance| Metric | ORRF | BBOT |
|---|---|---|
| Price | $42.20 | $9.07 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | ★ $42.00 | $24.00 |
| AVG Volume (30 Days) | 89.4K | ★ 248.1K |
| Earning Date | 04-21-2026 | 05-26-2026 |
| Dividend Yield | ★ 3.29% | N/A |
| EPS Growth | ★ 182.43 | 99.93 |
| EPS | ★ 2.21 | N/A |
| Revenue | ★ $37,144,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.15 | N/A |
| P/E Ratio | $19.05 | ★ N/A |
| Revenue Growth | ★ 36.00 | N/A |
| 52 Week Low | $31.88 | $7.00 |
| 52 Week High | $43.81 | $14.87 |
Technical Indicators
Market Signals| Indicator | ORRF | BBOT |
|---|---|---|
| Relative Strength Index (RSI) | 47.88 | 52.90 |
| Support Level | $41.15 | $7.99 |
| Resistance Level | $42.48 | $9.49 |
| Average True Range (ATR) | 0.73 | 0.48 |
| MACD | -0.24 | -0.01 |
| Stochastic Oscillator | 36.36 | 53.70 |
Price Performance
Historical ComparisonAbout ORRF Orrstown Financial Services Inc
Orrstown Financial Services Inc is a financial holding company. Through its subsidiaries, it operates in the community banking segment and engages in lending activities, including commercial, residential, commercial mortgages, construction, municipal, and various forms of consumer lending and deposit services, including checking, savings, time, and money market deposits. The Group also provides fiduciary, investment advisory, insurance, and brokerage services. It offers services to individuals, professionals, small businesses, and other enterprises across different locations in the United States through its branch network and client service centers.
About BBOT BridgeBio Oncology Therapeutics Inc.
BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects.